Live feed08:05:00·441dPRReleasevia QuantisnowCyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label Sub-Study in Patients (< 3 Years Old)ByQuantisnow·Wall Street's wire, on your screen.CYTH· Cyclo Therapeutics Inc.Health Care
